MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Recruiting · NCT06191965 · Registry updated 2025-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction | Cognition Disorders, Cognitive Dysfunction, Schizophrenia Spectrum and Other Psychotic Disorders, cognitive disorder, psychiatric disorder, schizophrenia | Recruiting | Phase 2 / Phase 3 | 2025-09-25 | NCT06191965 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mclean Hospital | 54 |
| University of Lausanne | 14 |
| Yale University | 458 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McLean Hospital | Belmont | United States | 47 |
| University of Lausanne | Lausanne | Switzerland | 2 |
| Yale School of Medicine | New Haven | United States | 7 |